Patent · US Active

Substituted phenyl oxazolone compounds

US12331045B2 · kind B2 · utility

0Cited by
0References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2024
Grant dateJun 17, 2025
Priority date
Expiry dateDec 4, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B59/002
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of Formula (I): or stereoisomers, tautomers, or salts thereof, wherein each R is independently H or D. Also disclosed are methods of using such compounds to decrease the levels of IKZF1-4 proteins; and pharmaceutical compositions comprising the compound. The compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.